Srinivas Akkaraju's Net Worth

Srinivas Akkaraju's net worth is estimated to be at least $46,147,612.91 as of 10/01/2022. CoreStreet's estimation of Srinivas Akkaraju's net worth is based on their sale of stock and current holding of stock.

Srinivas Akkaraju is Director at Chinook Therapeutics Inc. They have executed at least 18 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,215,000 units of KDNY stock on 11/15/2021. Their biggest sale was on 02/19/2019 when they sold 23,438 units of Intercept Pharmaceuticals Inc stock for $3,018,345.64. They typically trade 2 times per year.

Total value of insider buys:
  • $38,169,061.64
Total value of insider sells:
  • $7,978,551.27
Most recent insider trade:
  • Nov. 15, 2021

Srinivas Akkaraju's Insider Trading History

Chinook Therapeutics IncTitleAmountPriceTypeTotal Value
Nov. 15, 2021
Director1,215,000$14.00Buy$17,010,000.00
Aug. 18, 2021
Director208,500$11.98Buy$2,497,830.00
Intercept Pharmaceuticals IncTitleAmountPriceTypeTotal Value
March 12, 2021
Director147,000$21.29Buy$3,129,630.00
March 10, 2021
Director90,000$20.96Buy$1,886,400.00
Aug. 28, 2019
Director5,207$60.32Buy$314,086.24
Aug. 22, 2019
Director67,784$66.37Buy$4,498,824.08
Feb. 19, 2019
Director23,438$128.78Sell$3,018,345.64
Nov. 12, 2014
Director2,000$167.19Buy$334,380.00
Jan. 16, 2014
Director3,250$267.94Sell$870,805.00
Syros Pharmaceuticals IncTitleAmountPriceTypeTotal Value
June 25, 2020
Director54,972$11.15Sell$612,937.80
June 23, 2020
Director50,953$11.11Sell$566,087.83
April 9, 2019
Director533,332$7.50Buy$3,999,990.00
Jan. 31, 2018
Director209,424$9.55Buy$1,999,999.20
Dec. 14, 2017
Director109,774$9.03Buy$991,259.22
Aravive IncTitleAmountPriceTypeTotal Value
Dec. 2, 2019
Director133,333$11.30Buy$1,506,662.90
Seagen IncTitleAmountPriceTypeTotal Value
Nov. 21, 2019
Director17,500$119.78Sell$2,096,150.00
June 14, 2013
Director5,000$32.75Sell$163,750.00
May 10, 2013
Director17,500$37.17Sell$650,475.00